Your browser doesn't support javascript.
loading
Impact of belantamab mafodotin-induced ocular toxicity on outcomes of patients with advanced multiple myeloma.
Abeykoon, Jithma P; Vaxman, Julia; Patel, Sanjay V; Kumar, Shaji; Malave, Gabriella C; Young, Kimberly S; Ailawadhi, Sikander; Larsen, Jeremy T; Dispenzieri, Angela; Muchtar, Eli; Gonsalves, Wilson I; Kourelis, Taxiarchis; Leung, Nelson; Warsame, Rahma; Go, Ronald S; Bergsagel, Leif; Lacy, Martha Q; Rajkumar, S Vincent; Gertz, Morie A; Kapoor, Prashant.
Affiliation
  • Abeykoon JP; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Vaxman J; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Patel SV; Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kumar S; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Malave GC; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Young KS; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Ailawadhi S; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USA.
  • Larsen JT; Division of Hematology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Dispenzieri A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Muchtar E; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Gonsalves WI; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Kourelis T; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Leung N; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Warsame R; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Go RS; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Bergsagel L; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Lacy MQ; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Gertz MA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Kapoor P; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Br J Haematol ; 199(1): 95-99, 2022 10.
Article in En | MEDLINE | ID: mdl-35694818
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Multiple Myeloma Limits: Humans Language: En Journal: Br J Haematol Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates / Multiple Myeloma Limits: Humans Language: En Journal: Br J Haematol Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido